March 2, 2020
President Trump Meeting with Pharmaceutical Executives on Coronavirus
https://web.archive.org/web/20200303153010/https://www.whitehouse.gov/briefings-statements/remarks-president-trump-members-coronavirus-task-force-meeting-pharmaceutical-companies/

Present in the room with President Trump:

Dr. Deborah Birx addressed as "one of the leading experts in infectious diseases in the world."

Alex Azar Secretary HHS

Vice President Mike Pence

Dr Anthony (Tony) Fauci, the Director of the National Institute of Allergy and Infectious Diseases

Dr Robert (Bob) Redfield, the Director of CDC

Dan Menichella, CEO of CureVac

Ms Emma Walmsley from GlaxoSmithKline

John Shiver, head of Vaccine Research and Development for Sanofi vaccines

Lenny Schleifer, the founder and CEO of Regeneron, a monoclonal antibody primarily centered company

Stéphane Bancel, CEO of Moderna.

Mr Daniel O'Day from Gilead Sciences

Dr. Stephen Hahn, new head of the FDA

Dr Dolsten chief scientist for Pfizer 
(at this point Pfizer had not collaborated with BioNTech which happened March 17, 2020
https://totalityofevidence.com/timeline/pfizer-biontech-announce-vaccine-collaboration/)

Dr Paul Stoffels, Vice Chairman and Chief Scientific Officer for Johnson & Johnson, working with a new vaccine platform

Dr Joseph Kim Head of Inovio Pharmaceuticals an American biotech company, Inovio is the leader in coronavirus vaccine development in the world!

Dr Anne Schuchat from CDC

Mr Erck of Novavax - our company is focused on emerging infectious diseases.  We’ve made two coronavirus vaccines. MERS & SARS.  For coronavirus "we’re going to the nonhuman primates this week with the coronavirus vaccine candidate"